Home ›

Intimate Partner Violence

in
April, 2012 | Vol: 1 Issue: 2

In this issue

Learning Objective

Learning Objectives, TCRBH, April 2012

Article

Counseling for Intimate Partner Violence

Annie Mortimer (not her real name), a graduate student in her late 20s, came to the Safe Horizon Community Program after her therapist of six months had terminated services with her.

Pharmacological Considerations in Treating Patients Exposed to Intimate Partner Violence

Patients who have been exposed to intimate partner violence (IPV) often develop significant psychiatric symptoms, most commonly insomnia, anxiety, and depression. Despite the fact that a majority of those exposed to IPV seek medical care and treatment, they don’t tend to disclose their histories of abuse.

Six Critical Mistakes to Avoid When Treating Survivors of Intimate Partner Violence

Therapy needs to be tailored to the issues, the patient, and the risk factors in her environment. This is especially true in domestic violence, where our urge to spirit a battered woman away from her partner may feel like a good idea to us, but not reflect a client’s best interests, and could even endanger her.

Expert Q&A

Understanding Battered Women

Dr. Walker, you have been called “the mother of the battered woman syndrome” because your research helps explain why battered women have trouble leaving violent domestic relationships, especially romantic relationships. What is battered woman syndrome?

Research Update

CBT Helps Low-Functioning Patients with Schizophrenia

A recent study of patients with schizophrenia has shown significant improvement in functioning from a psychosocial treatment—the first time these results have been seen.

Click here to view mobile site

Current Issue

Insomnia

May, 2013
Vol: 2 Issue: 3
Read More
Previous Issues

Topics

ADHD
Antidepressants
Antipsychotics
Anxiety Disorder
Autism Spectrum Disorder
Benzodiazepines
Bipolar Disorder
Brain Devices
Child Psychiatry
Cognitive Behavioral Therapy
Computers in Psychiatric Practice
Cultural Competence
Dementia
Depressive Disorder
Diagnostic Testing
DSM
Eating Disorders
End of Life Care
Free Articles
Gender & Sexuality
Genetics and Psychiatry
Health Care Policy
HIPAA
Hypnotics
Laboratory Testing in Psychiatry
Learning & Developmental Disabilities
Medical Comorbidities
Mood Stabilizers
Natural Medications
Neuroscience in Psychiatry
Novel Anticonvulsants
OCD
Personality Disorders
Pharmaceutical Industry
Practice Tools and Tips
Psychopharmacology Tips
Psychotherapy
PTSD
Research Updates
Risk Management
Seasonal Affective Disorder
Sexual Dysfunction
Sleep Disorders
Smoking Cessation Agents
Substance Abuse
Understanding Psychiatric Research
Weight Loss Medications
Women's Issues in Psychiatry

Search

Follow Us

The Carlat Report Twitter Feed
Carlat Report RSS
The Carlat Report Blog
The Carlat Report Fan Page

Earn CME Credit Instantly!

Not quite ready for a one-year subscription to The Carlat Psychiatry Report? Need CME credits on a particular topic or on a tight deadline?

Try our A la Carte CME! You can buy single or multiple credits of continuing education, without committing to a year-long newsletter subscription.

Click here to purchase A la Carte CME credits

Already an A la Carte subscriber? Click here to go to your a la carte page

Murray Kumperminc
Murray Kuperminc, PhD, is the editor-in-chief of TCRBH. Dr. Kuperminc is a psychologist in private practice in West Hartford, Connecticut and was the editor of The Complete Practitioner from January 1998 to June 2011.

The 2012 Carlat Atypical Antipsychotics Table is Now Available!

With all the atypicals on the market, it's hard to keep track of indications, dosages, and all the other relevant facts for each drug. Use this table for summaries on these meds, their uses, their side effects, and a whole slew of other information.

See the Atypical Antipsychotics table!

TCRBH Continuing Education
Accredited/Approved/Accepted by:

  • ACCME
  • AMA
  • APA
  • ASWB
  • ANCC
  • AAPA